• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯己定缓释给药系统在唐氏综合征人群中的局部应用。

Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population.

作者信息

Stabholz A, Shapira J, Shur D, Friedman M, Guberman R, Sela M N

机构信息

Faculty of Dental Medicine, Hebrew University-Hadassah, Jerusalem.

出版信息

Clin Prev Dent. 1991 Sep-Oct;13(5):9-14.

PMID:1839722
Abstract

The effect of local applications of sustained-release delivery polymer containing chlorhexidine as an adjunct to mechanical plaque removal was studied in institutionalized children with Down's syndrome. Thirty children, ages 8-13, participated in the study. Clinical parameters (P1I, GI, papillary bleeding) were recorded and bacterial samples from selected permanent teeth were collected and processed before and following treatment. Following the registration of clinical findings and collection of plaque, all children had their teeth scaled and polished and were randomized into three treatment groups of ten subjects each: Subjects in group I had their teeth coated with ethyl cellulose containing chlorhexidine; those in group II had their teeth coated with placebo polymer and those in group III received no further treatment. Individual oral hygiene habits were not interfered with. The application of the solutions to the respective groups was done every 3 days for 21 days. Chlorhexidine treatment significantly reduced the PLI, GI total aerobic counts and S. viridans counts compared to no treatment. The placebo group showed similar effects to that of the chlorhexidine-treated group except for the total aerobic counts which were not affected. The results suggest that the use of chlorhexidine in a sustained-release dosage form applied to the tooth surfaces may prove useful in the control of plaque and its sequela in children with Down's syndrome.

摘要

在患有唐氏综合征的福利院儿童中,研究了含氯己定的缓释递送聚合物局部应用作为机械性去除牙菌斑辅助手段的效果。30名8至13岁的儿童参与了该研究。记录临床参数(菌斑指数、牙龈指数、龈乳头出血情况),并在治疗前后收集选定恒牙的细菌样本并进行处理。在记录临床结果和收集牙菌斑后,所有儿童均进行了洗牙和抛光,然后随机分为三个治疗组,每组10名受试者:第一组受试者的牙齿涂有含氯己定的乙基纤维素;第二组受试者的牙齿涂有安慰剂聚合物;第三组受试者不再接受进一步治疗。个人口腔卫生习惯未受干扰。每隔3天对各治疗组进行一次溶液涂抹,共进行21天。与未治疗相比,氯己定治疗显著降低了菌斑指数、牙龈指数、需氧菌总数和草绿色链球菌计数。安慰剂组除需氧菌总数未受影响外,显示出与氯己定治疗组相似的效果。结果表明,将氯己定以缓释剂型应用于牙齿表面可能有助于控制唐氏综合征儿童的牙菌斑及其后遗症。

相似文献

1
Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population.氯己定缓释给药系统在唐氏综合征人群中的局部应用。
Clin Prev Dent. 1991 Sep-Oct;13(5):9-14.
2
Clinical and microbiological effects of chlorhexidine and arginine sustained-release varnishes in the mentally retarded.洗必泰和精氨酸缓释清漆在智障人群中的临床及微生物学效应
Spec Care Dentist. 1994 Jul-Aug;14(4):158-63. doi: 10.1111/j.1754-4505.1994.tb01124.x.
3
Plaque inhibition by sustained release of chlorhexidine from removable appliances.通过可摘矫治器持续释放氯己定实现牙菌斑抑制
J Dent Res. 1985 Nov;64(11):1319-21. doi: 10.1177/00220345850640111401.
4
Inhibition of plaque accumulation under periodontal dressing by sustained-release varnish of chlorhexidine.
Clin Prev Dent. 1992 May-Jun;14(3):29-33.
5
Evaluation of the mechanical and chemical control of dental biofilm in patients with Down syndrome.唐氏综合征患者口腔生物膜机械和化学控制的评估
Community Dent Oral Epidemiol. 2009 Oct;37(5):463-7. doi: 10.1111/j.1600-0528.2009.00488.x. Epub 2009 Jul 22.
6
New sustained release dosage form of chlorhexidine for dental use: use for plaque control in partial denture wearers.牙科用洗必泰新缓释剂型:用于局部义齿佩戴者的牙菌斑控制。
J Oral Rehabil. 1984 Sep;11(5):477-82. doi: 10.1111/j.1365-2842.1984.tb00600.x.
7
The effect of local application of chlorhexidine on plaque and gingivitis.局部应用洗必泰对牙菌斑和牙龈炎的影响。
N Z Dent J. 1996 Mar;92(407):13-5.
8
The use of sustained release delivery of chlorhexidine for the maintenance of periodontal pockets: 2-year clinical trial.使用洗必泰缓释制剂维持牙周袋深度:两年临床试验。
J Periodontol. 1991 Jul;62(7):429-33. doi: 10.1902/jop.1991.62.7.429.
9
Clinical evaluation of chlorhexidine for the control of dental biofilm in children with special needs.洗必泰用于控制特殊需求儿童口腔生物膜的临床评估。
Community Dent Health. 2011 Sep;28(3):222-6.
10
The comparison of various oral hygiene strategies in neuromuscularly disabled individuals.神经肌肉残疾个体中各种口腔卫生策略的比较。
J Contemp Dent Pract. 2004 Nov 15;5(4):23-31.

引用本文的文献

1
Multiple Sessions of Antimicrobial Photodynamic Therapy Improve Periodontal Outcomes in Patients with Down Syndrome: A 12-Month Randomized Clinical Trial.多次抗菌光动力疗法改善唐氏综合征患者的牙周治疗效果:一项为期12个月的随机临床试验
Dent J (Basel). 2025 Jan 15;13(1):33. doi: 10.3390/dj13010033.
2
Efficacy of periodontal treatment modalities in Down syndrome patients: a systematic review and meta-analysis.唐氏综合征患者牙周治疗方式的疗效:一项系统评价与荟萃分析
Evid Based Dent. 2024 Dec;25(4):213-214. doi: 10.1038/s41432-024-01055-x. Epub 2024 Aug 25.
3
Comparing the Effectiveness of Octenidine Hydrochloride and Chlorhexidine Gluconate Mouthrinses in Reducing Plaque and Oxidative Stress in Institutionalized Children with Down Syndrome.
比较盐酸奥替尼啶和葡萄糖酸氯己定漱口水在降低唐氏综合征机构收养儿童牙菌斑和氧化应激方面的效果。
Int J Clin Pediatr Dent. 2024 Apr;17(4):437-441. doi: 10.5005/jp-journals-10005-2816.
4
Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review.唐氏综合征患者的预防与牙周治疗:一项系统综述
PLoS One. 2016 Jun 29;11(6):e0158339. doi: 10.1371/journal.pone.0158339. eCollection 2016.
5
Placebo interventions for all clinical conditions.针对所有临床病症的安慰剂干预措施。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD003974. doi: 10.1002/14651858.CD003974.pub3.